Home > Media KIt > News Room

Unaudited Financial Results for the Quarter ended 30th June, 2009
Sr. No. Particulars Quarter ended  30.06.2009 (Unaudited) Quarter ended  30.06.2008 (Unaudited) Year ended 31.03.2009 (Audited)   
1(a) Net Sales 4255.39 3842.16 16510.22
(b) Other Operating Income 2.52 2.05 14.78
Total (1a+1b) 4257.91 3844.21 16525.00
2 Expenditure
a)  (Increase) / Decrease in Stock-in-Trade & Work in Progress (142.62) (167.38) (188.98)
b)  Consumption of Raw Materials 3088.01 2788.67 11734.66
c)  Employee Cost 512.61 422.06 1858.00
d) Depreciation and Amortisation 1137.85 1175.87 4551.43
e)  Other Expenditure 642.77 631.78 2829.37
Total  5238.62 4851.00 20784.48
3 Profit / (Loss) from Operations before Other Income, Interest and Exceptional Items (1-2) (980.71) (1006.79) (4259.48)
4  Other Income                         -                          -                           -  
5 Profit / (Loss) before Interest and Exceptional Items (3+4) (980.71) (1006.79) (4259.48)
6 Interest  39.24 47.45 201.12
7 Profit / (Loss) after Interest but before Exceptional Items (5-6) (1019.95) (1054.24) (4460.60)
8 Exceptional Items - Income/(Expense)                        -                          -                           -  
9 Profit / (Loss) from Ordinary Activities before Tax (7-8) (1019.95) (1054.24) (4460.60)
10 Tax Expense - Fringe Benefit Tax                        -   3.30 28.06
11 Profit / (Loss) from Ordinary Activities after Tax (9-10) (1019.95) (1057.54) (4488.66)
12 Extraordinary Items-Income/(Expense)                        -                          -   804.34
13 Net Profit /(Loss) for the period  (11-12) (1019.95) (1057.54) (3684.32)
14 Paid-up Equity Share Capital of Face Value of Rs.2/- each 7146.06 7146.06 7146.06
15 Reserves excluding Revaluation reserves                        -                          -   12346.39
16 a) Earning Per Share before Extraordinary Items (in Rs.)
- Basic & Diluted (0.29) (0.30) (1.26)
b) Earning Per Share after Extraordinary Items (in Rs.)
- Basic & Diluted (0.29) (0.30) (1.03)
17 Public Shareholding
Number of Shares 200805346 201964202 200805346
 Percentage of shareholding 56.20 56.52 56.20
18 Promoters and Promoter Group Shareholding
a) Pledged / Encumbered
 - Number of Shares 1768856 NA 1768856
- Percentage of shares (as a % of the total shareholding of promoter and promoter group) 1.13 NA 1.13
- Percentage of shares (as a % of the total share capital of the company) 0.50 NA 0.50
b) Non-encumbered
    - Number of Shares 154761588 NA 154761588
- Percentage of shares (as a % of the total shareholding of promoter and promoter group) 98.87 NA 98.87
- Percentage of shares (as a % of the total share capital of the company) 43.31 NA 43.31

Notes:

1.The Company is exclusively engaged in the Pharmaceutical Business segment. Capital employed  as on June 30, 2009 is Rs. 58487.26 Lacs.

2.During the quarter, the company forfeited upfront money of Rs. 270.40 Lacs on account of non-conversion of Naked Warrants into Equity Shares within stipulated period as prescribed under SEBI (DIP) guidelines and this amount is transfered to Capital Reserve.

3.The modified scheme of arrangement and compromise, under Section 391 of Companies Act, 1956, with Fixed Deposit Holders was put to vote in the meetings of Fixed Deposit Holders and Equity Share Holders as per orders of Hon'ble High Court of Himachal Pradesh at Shimla. Pending adjudication of this scheme, interest of Rs.288.44 Lacs on Fixed Deposits and loans under settlement, has been taken under contingent liabilities.

4.Consolidated Income from Operations, Profit(Loss) after tax and EPS for the quarter ended June 30th, 2009 stands at Rs.4651.66 Lacs, Rs.(-)1008.98 Lacs & Rs.(-) 0.28 respectively.

5.During the Quarter, no shareholder complaint was received.6.The above results, after approval by audit committee have been adopted by the Board of Directors at its meeting held on 27th July, 2009. A limited review of the same has been conducted by the Statutory Auditors.

  For and on behalf of the Board
Place: New Delhi
Date: 27.07.2009
(Sushil Suri)
Chairman & Managing Director